News and Position Papers

Strategic autonomy of the pharmaceutical supply chain is essential to the sustainability of patient care in the U.S. and the…

In 2019, EFCG has approached the Commission to alert them about the risk of future shortages of medicines, based on…

As producers of the essential building blocks used to make medicines, EFCG welcomes the Commission’s initiative to ensure a future-proof…

EFCG and IPEC Europe continue to make the case that the importance of novel excipients needs to be fully recognised…

Don’t miss this very interesting webinar on ‘Green Chemistry: Inspiring Sustainable Drug Manufacturing’ organised by CPhI Online on 28th April…

Novel excipients are essential for the development of new medicines and vaccines. They foster patient access to innovative and affordable…

EFCG is honoured to have taken part in today’s high-profile launch of the EU Commission’s Structured Dialogue of the EU…

DCAT Article – 09/12/2020 By Patricia Van Arnum – Editorial Director DCAT issued a must-read article on the European Commission’s…

C&EN article – 27/11/2020By Rick Mullin Luís Gomes, the Chairman of the EFCG Pharmaceutical Activities Committee and Maggie Saykali, Director…